Vaccine effectiveness against symptomatic SARS-CoV-2 infection in adults aged 65 years and older in primary care: I-MOVE-COVID-19 project, Europe, December 2020 to May 2021

Euro Surveill. 2021 Jul;26(29). doi: 10.2807/1560-7917.ES.2021.26.29.2100670.ABSTRACTWe measured COVID-19 vaccine effectiveness (VE) against symptomatic SARS-CoV-2 infection at primary care/outpatient level among adults ≥ 65 years old using a multicentre test-negative design in eight European countries. We included 592 SARS-CoV-2 cases and 4,372 test-negative controls in the main analysis. The VE was 62% (95% CI: 45-74) for one dose only and 89% (95% CI: 79-94) for complete vaccination. COVID-19 vaccines provide good protection against COVID-19 presentation at primary care/outpatient level, particularly among fully vaccinated individuals.PMID:34296676 | DOI:10.2807/1560-7917.ES.2021.26.29.2100670

Source: Euro Surveill - July 23, 2021 Category: Infectious Diseases Authors: Esther Kissling Mariette Hooiveld Virginia Sandonis Mart ín Iv án Martínez-Baz Naoma William Ana-Maria Vilcu Clara Mazagatos Lisa Domegan Simon de Lusignan Adam Meijer Ausenda Machado Mia Brytting Itziar Casado Josephine-L K Murray Sylvie Belhillil Amp Source Type: research